Evergen
Kevin Breeden, MBA, serves as Chief Operating Officer at RTI Surgical® since February 2024, focusing on operational optimization and customer-centric improvement programs. Previously, Kevin held senior leadership roles at Integra LifeSciences from 2010 to July 2023, including Senior Vice President Operations for the Tissue Technologies division, overseeing global operations with more than 500 employees, and Senior Vice President Operations, Codman Specialty Surgery, following Integra’s acquisition of Codman Neurosurgery. Prior experience includes leading Integra Miltex as President after its acquisition and serving as Vice President Operations at DENTSPLY INTERNATIONAL, a leading dental manufacturer. Kevin holds an MBA from York College of Pennsylvania and a Bachelor of Science in Accounting and Finance from Penn State University.
This person is not in any offices
Evergen
4 followers
Evergen is a leading Contract Development and Manufacturing Organization (CDMO) pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine. We are expert partners to Original Equipment Manufacturers (OEMs), working with them to identify clinical problems and develop customized solutions that promote healing, accelerate recovery, and help prevent complications. Using our extensive portfolio of biological materials, we focus on specialized clinical segments, including plastic and reconstructive surgery, sports medicine and orthopedics, cardiac, and neurosurgery.